Zentalis Pharmaceuticals, Inc. (ZNTL) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 26.86M | 0 | 0 | 40.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | -100% | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 151K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 324K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | 0.8% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -151K | 0 | 0 | 0 | 0 | 26.86M | 0 | 0 | 40.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | 100% | - | - | 99.2% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -100% | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 37.7M | 37.39M | 33.73M | 36.06M | 45.62M | 76.71M | 51.43M | 65.15M | 65M | 67.92M | 62.72M | 103.92M | 64.95M | 51.75M | 54.19M | 63.46M | 57.88M | 48.19M | 62.87M | 55.13M |
| OpEx % of Revenue | - | - | - | - | - | 285.55% | - | - | 160.26% | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 8.99M | 7.91M | 10.78M | 7.3M | 10.58M | 40.01M | 14.61M | 16.76M | 15.42M | 16.36M | 15.95M | 15.66M | 16.37M | 11.14M | 12.01M | 19.64M | 11.77M | 9.75M | 8.87M | 10.36M |
| SG&A % of Revenue | - | - | - | - | - | 148.91% | - | - | 38.01% | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 28.72M | 29.49M | 22.95M | 27.61M | 27.25M | 32.97M | 36.82M | 48.39M | 49.59M | 51.56M | 46.77M | 42.68M | 48.58M | 40.62M | 42.18M | 43.83M | 46.11M | 38.44M | 54M | 44.77M |
| R&D % of Revenue | - | - | - | - | - | 122.74% | - | - | 122.25% | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 1000K | 1000K | 1000K | 0 | -1 | 0 | 1 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -37.85M | -37.39M | -33.73M | -36.06M | -45.62M | -49.85M | -51.43M | -65.15M | -24.77M | -67.92M | -62.72M | -103.92M | -64.95M | -51.75M | -54.19M | -63.46M | -57.88M | -48.19M | -62.87M | -55.13M |
| Operating Margin % | - | - | - | - | - | -185.55% | - | - | -61.06% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 17.03% | 24.99% | 34.41% | 44.65% | -84.22% | 26.61% | 17.99% | 37.31% | 61.87% | -31.24% | -15.73% | -63.75% | -12.22% | -7.39% | 13.8% | -15.11% | -14.96% | -19.75% | -80.83% | -101.39% |
| EBITDA | -37.7M | -37.24M | -33.57M | -35.9M | -45.36M | -49.53M | -51.11M | -64.82M | -24.44M | -67.58M | -62.37M | -103.57M | -64.59M | -51.4M | -53.82M | -63.11M | -57.53M | -47.98M | -62.73M | -55.01M |
| EBITDA Margin % | - | - | - | - | - | -184.37% | - | - | -60.26% | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 16.88% | 24.82% | 34.31% | 44.62% | -85.59% | 26.71% | 18.05% | 37.41% | 62.16% | -31.5% | -15.89% | -64.11% | -12.27% | -7.11% | 14.21% | -14.72% | -14.46% | -19.33% | -80.7% | -101.23% |
| D&A (Non-Cash Add-back) | 151K | 157K | 160K | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K |
| EBIT | -37.85M | -37.39M | -26.69M | -34.91M | -37.83M | -46.11M | -51.43M | -65.15M | -24.77M | -67.92M | -62.72M | -58.35M | -64.95M | -51.75M | -54.19M | -63.46M | -57.88M | -38.19M | -62.87M | -55.13M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -344.51K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 493 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 345K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.62M | 2.62M | 7.04M | 9.18M | -2.66M | 2.17M | 11.25M | -22.86M | 34.95M | 6.85M | 7.21M | -9.25M | 1.8M | -3.59M | -466K | -4.91M | -1.32M | -1.74M | 51.68M | 115K |
| Pretax Income | -35.23M | -34.77M | -26.69M | -26.87M | -48.28M | -47.68M | -40.19M | -88.01M | 10.18M | -61.07M | -55.51M | -113.17M | -63.15M | -55.34M | -54.66M | -68.38M | -59.2M | -49.94M | -11.19M | -55.02M |
| Pretax Margin % | - | - | - | - | - | -177.47% | - | - | 25.11% | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 120K | 442K | 0 | 0 | 0 | -205K | -27K | 266K | 143K | -135K | 31K | -605K | 108K | -360K | -159K | 17K | 33K | 159K | -697K | 45K |
| Effective Tax Rate % | -0.34% | -1.27% | 0% | 0% | 0% | 0.43% | 0.07% | -0.3% | 1.4% | 0.22% | -0.06% | 0.53% | -0.17% | 0.65% | 0.29% | -0.02% | -0.06% | -0.32% | 6.23% | -0.08% |
| Net Income | -35.35M | -35.22M | -26.69M | -26.87M | -48.28M | -47.47M | -40.16M | -88.28M | 10.07M | -60.92M | -55.53M | -112.53M | -63.22M | -54.97M | -54.4M | -68.36M | -59.08M | -50.06M | -4.19M | -54.57M |
| Net Margin % | - | - | - | - | - | -176.71% | - | - | 24.82% | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 26.78% | 25.82% | 33.53% | 69.56% | -579.53% | 22.07% | 27.68% | 21.55% | 115.93% | -10.82% | -2.07% | -64.62% | -7.01% | -9.81% | -1198.04% | -25.26% | -18.39% | -24.21% | 87.87% | -103.2% |
| Net Income (Continuing) | -35.35M | -35.22M | -26.69M | -26.87M | -48.28M | -47.47M | -40.16M | -88.28M | 10.04M | -60.94M | -55.54M | -112.56M | -63.26M | -54.98M | -54.5M | -68.39M | -59.24M | -50.09M | -10.49M | -55.06M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107K | 129K | 141K | 178K | 221K | 234K | 333K | 368K | 528K | 564K | 23.76M |
| EPS (Diluted) | -0.50 | -0.49 | -0.37 | -0.37 | -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.09 | -1.34 |
| EPS Growth % | 25.37% | 26.87% | 33.93% | 70.16% | -578.57% | 22.09% | 29.11% | 32.97% | 113.59% | -6.17% | 14.13% | -50.41% | 18.9% | 27.03% | -879.77% | 8.21% | -2.42% | -9.9% | 89.68% | -71.79% |
| EPS (Basic) | -0.50 | -0.49 | -0.37 | -0.37 | -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.09 | -1.34 |
| Diluted Shares Outstanding | 70.26M | 71.67M | 72.14M | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 71.19M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M |
| Basic Shares Outstanding | 70.26M | 71.67M | 72.14M | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 70.9M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |